Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Express Scripts
Covington
Mallinckrodt
Argus Health
UBS

Generated: July 21, 2019

DrugPatentWatch Database Preview

Patent: 6,201,105

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,201,105
Title: Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)
Abstract:Tumor necrosis factor receptor proteins, DNAs and expression vectors encoding TNF receptors, and processes for producing TNF receptors as products of recombinant cell culture, are disclosed.
Inventor(s): Smith; Craig A. (Seattle, WA), Goodwin; Raymond G. (Seattle, WA), Beckmann; M. Patricia (Poulsbo, WA)
Assignee:
Application Number:09/233,461
Patent Claims:see list of patent claims

Details for Patent 6,201,105

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02 ➤ Sign Up ➤ Sign Up RX Orphan company
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02 ➤ Sign Up ➤ Sign Up RX Orphan company
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 6,201,105

Country Patent Number Publication Date
South Africa 9007072 Oct 30, 1991
World Intellectual Property Organization (WIPO) 9103553 Mar 21, 1991
World Intellectual Property Organization (WIPO) 9319777 Oct 14, 1993
World Intellectual Property Organization (WIPO) 9406476 Mar 31, 1994
United States of America 2002006391 Jan 17, 2002
United States of America 2003082736 May 01, 2003
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Healthtrust
McKinsey
US Department of Justice
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.